Integral Diagnostics Announces New MD & CEO Start Date
Key points
- Jason Martinez appointed as new Managing Director and CEO
- Commencing role on 6 August 2026 after extended garden leave
- Dr Ian Kadish to continue as MD & CEO until transition
Full summary
Integral Diagnostics Limited (ASX: IDX) has announced the commencement date for its new Managing Director and Chief Executive Officer, Jason Martinez. Mr Martinez was appointed to the role in November 2025, and IDX has now confirmed that he will commence in the position on 6 August 2026, following an extended garden leave period with his former employer. Until Mr Martinez's start date, the current Managing Director and CEO, Dr Ian Kadish, will continue serving in the role to ensure a seamless leadership transition for the company. IDX is a leading provider of medical imaging services across Australia and New Zealand, employing some of Australasia's leading radiologists and diagnostic imaging specialists. The company operates under a unique medical leadership model that ensures quality patient care, service and access.
Summary generated by a large language model. Please interpret with care.